Motegrity is a prescription medication used to treat chronic constipation in adults. It belongs to a class of drugs called serotonin receptor agonists. The drug selectively activates the 5-ht4 receptor in the enteric nervous system. Activation of this receptor enhances intestinal motility by increasing peristaltic waves. It also promotes secretion of fluid and electrolytes into the gut. These effects collectively accelerate the movement of stool through the colon. The resulting increase in bowel movements provides symptomatic relief for patients with chronic constipation.

Motegrity is a prescription medication classified as a selective serotonin 5-ht4 receptor agonist. It is indicated for the treatment of chronic constipation in adult patients. The drug works by selectively stimulating serotonin receptors in the enteric nervous system. This stimulation leads to increased acetylcholine release from enteric neurons. The elevated acetylcholine enhances peristaltic contractions of the intestinal wall. As a result, intestinal transit time is reduced, facilitating more frequent bowel movements. The overall effect is an improvement in stool frequency and consistency for patients with chronic constipation. Motegrity's pharmacological activity therefore centers on modulating gastrointestinal motility through serotonergic pathways.

Motegrity may cause gastrointestinal discomfort in some patients while taking it. It can occasionally lead to headache or dizziness during treatment. Some individuals experience mild nausea or loss of appetite. Constipation or diarrhea may occur as part of the drug's effect profile. Skin reactions such as rash or itching have been reported rarely. Fatigue or general weakness may be noted in certain cases. The medication can interact with other drugs affecting gut motility. Overall the side effect occurrence is generally mild and transient.

Motegrity is a prescription medication used to treat chronic constipation. Common side effects include headache, abdominal pain, and diarrhea. Some users may experience nausea or vomiting as part of the reaction profile. Less frequent adverse events can involve dizziness or fatigue. Rarely, the drug has been associated with mood changes such as irritability or depression. Most side effects are mild and typically resolve without intervention. The safety profile is considered comparable to other agents in its class.